SCHW
43
-2
CVS
49
12
FLR
42
-3
ADM
30
2
ABT
48
-2
COF
60
3
FRT
36
-9
PEP
36
3
ORCL
60
-11
CF
36
3
ROK
48
4
KIM
48
10
WAT
37
-4
SWK
56
3
SYF
67
2
DOV
72
3
PEG
43
2
WRK
52
2
AAL
20
2
AEP
54
-2
SCHW
43
-2
CVS
49
12
FLR
42
-3
ADM
30
2
ABT
48
-2
COF
60
3
FRT
36
-9
PEP
36
3
ORCL
60
-11
CF
36
3
ROK
48
4
KIM
48
10
WAT
37
-4
SWK
56
3
SYF
67
2
DOV
72
3
PEG
43
2
WRK
52
2
AAL
20
2
AEP
54
-2
Financhill
Back

Spyre Therapeutics Stock Predictions

Sell
39

SYRE
Spyre Therapeutics

Last Price:
25.33
Seasonality Move:
49.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Spyre Therapeutics Stock Forecast

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 77.3% based on the past 8 years of stock performance.
  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is Spyre Therapeutics Stock Undervalued?
    The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Spyre Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 77.3% based on the past 8 years of stock performance.

Spyre Therapeutics Stock Rating

Sell
39
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics overpriced?

  • Spyre Therapeutics has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

Spyre Therapeutics Stock Price History

Is SYRE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com

52-Week Data

52-Week High:
47.97
52-Week Low:
2.66

Prediction Charts

Market Cap:
1.02B
Price in USD:
25.43
Volume:
2.77M
Beta:
2.60

Technical Analysis

SMA50:
35.10
SMA100:
33.29
SMA200:
24.22
52-Wk Change:
628.13%

Stock Predictions

  • Is Spyre Therapeutics stock public?
    Yes, Spyre Therapeutics is a publicly traded company.
  • What is the Spyre Therapeutics stock quote today?
    The Spyre Therapeutics stock price is 25.43 USD today.
  • How to buy Spyre Therapeutics stock online?
    You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-29 32.62 31.97 33.72 31.83
May-30 32.28 34.05 34.34 32.07
May-31 34.45 34.95 35.83 34.13
Jun-3 35.00 36.67 37.50 34.09
Jun-4 36.58 34.10 37.30 33.05
Jun-5 34.12 35.13 35.34 33.85
Jun-6 35.43 34.61 35.89 33.37
Jun-7 34.09 33.67 35.79 33.09
Jun-10 33.78 36.47 36.97 33.58
Jun-11 36.04 37.98 38.22 35.14
Jun-12 38.51 37.00 38.90 36.81
Jun-13 36.77 32.36 36.77 30.99
Jun-14 31.78 31.51 32.60 30.74
Jun-17 31.62 25.43 32.00 24.00

Spyre Therapeutics Earnings

Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Spyre Therapeutics Forecast Revenue Growth

Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.